DMCC Speciality Chemicals Reports Strong FY26 Results, Proposes 25% Dividend

DMCC Speciality Chemicals Ltd announced robust audited financial results for the fiscal year and fourth quarter ended March 31, 2026. The company's net profit saw significant year-over-year growth, supported by strong demand. The board has recommended a final dividend of 25% for shareholders.

Financial Highlights for FY26

For the full fiscal year 2025-26, DMCC Speciality Chemicals reported a standalone net profit of ₹27.33 crore (₹2,733.18 lakh). This represents a substantial increase from ₹21.54 crore (₹2,153.97 lakh) in FY25. Consolidated net profit for FY26 stood at ₹27.33 crore (₹2,732.87 lakh), up from ₹21.53 crore (₹2,152.78 lakh) in the previous year.

The company also posted strong quarterly results. Standalone net profit for Q4 FY26 reached ₹7.66 crore (₹766.40 lakh), an increase from ₹6.47 crore (₹647.02 lakh) in Q4 FY25. Consolidated net profit for the fourth quarter was ₹7.65 crore (₹765.41 lakh), up from ₹6.47 crore (₹647.16 lakh) year-over-year.

In a separate board decision, Shri S. S. Dongare was appointed as the Cost Auditor for the financial year ending March 31, 2027.

Business Performance and Shareholder Returns

The significant profit growth achieved in FY26 highlights the company's strong operational performance and increasing market demand for its specialty chemicals and intermediates. The board's recommendation of a 25% final dividend, subject to shareholder approval at the upcoming Annual General Meeting, offers a direct return on investment.

Company Background

DMCC Speciality Chemicals Limited is an Indian firm focused on manufacturing specialty chemicals and intermediates.

Potential Risks

No significant risks were explicitly mentioned in the company's filings or identified in searches covering the relevant period.

Sector Performance Comparison

DMCC Speciality Chemicals' Q4 FY26 net profit growth of approximately 18.4% outperformed some sector peers. Aether Industries and Tatva Chintan Pharma Chem reported net profit declines for the same quarter. Neogen Chemicals showed positive momentum with an 11.6% profit increase in Q4 FY26, indicating a varied but generally recovering trend in the specialty chemicals segment.

Looking Ahead

Investors will be monitoring the shareholder approval of the 25% final dividend at the 105th Annual General Meeting. The company's future performance trajectory will also be a key focus, especially following these positive FY26 results. Dividend payments are expected within 30 days of AGM approval.